Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

INTRODUCTION. Right- and left-sided colorectal cancers (CRCs) differ in clinical and molecular characteristics. Some retrospective analyses suggested that patients with right-sided tumors derive less benefit from anti-epidermal growth factor receptor (EGFR) antibodies; however, molecular selection i...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2016
Subjects:
Gastrointestinal Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4978565/
https://ncbi.nlm.nih.gov/pubmed/27382031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0084
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items